Co-Diagnostics Inc (NASDAQ:CODX)
| 4.70 Delayed Data As of May 16 |  +0.15 / +3.30%Today’s Change | 3.66 Today|||52-Week Range 11.82 | -47.37% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $155.3M |
Company Description
Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.
Contact Information
Co-Diagnostics, Inc. 2401 South Foothill Drive Salt Lake City Utah 84109 |
Employees
Shareholders
| Mutual fund holders | 8.70% |
| Individual stakeholders | 7.03% |
| Other institutional | 13.02% |
Top Executives
| Dwight Howard Egan | Chairman, President & Chief Executive Officer |
| Brian L. Brown | Chief Financial Officer & Secretary |
| Jesse Montgomery | Chief Scientific Officer |
| Reed L. Benson | General Counsel |
